The U.S. has lifted the pause on the Johnson & Johnson vaccine, allowing to be administered again after an 11-day pause due to cases of rare blood clots.

Doctors at Bridgeport Hospital say having the vaccine as an option again would benefit many, and that the benefits outweigh the rare risks.

The rare blood clots were seen in 15 people out of nearly 8 million people who got the shot. All of them were women and most of them under 50 years old. Seven were hospitalized and three people died.

The panel says moving forward, it's critical younger women are aware of the risks of the vaccine and suggest adding a warning for women and health workers to see in leaflets at vaccine clinics.

The associate chief medical officer at Bridgeport Hospital says these risks seen in the vaccine are smaller than what we see in other commonly used medications.

"Everything has risks but these risks are just astronomically small. These are among the rarest side effects that are described with any medication and certainly with the vaccine, so I would feel perfectly safe for myself or one of my family members to receive this vaccine," said Dr. Gregory Buller.